Advertisement

Pharmacological interventions for the prevention of acute kidney injury after pediatric cardiac surgery: a network meta-analysis

  • Ioannis BellosEmail author
  • Dimitrios C. Iliopoulos
  • Despina N. Perrea
Original article
  • 11 Downloads

Abstract

Background

Acute kidney injury constitutes a major complication of cardiac surgery in pediatric patients. The present meta-analysis aims to accumulate current literature and assess the efficacy of pharmacological interventions in preventing postoperative renal dysfunction after congenital heart surgery.

Methods

Literature search was conducted using Medline (1966–2018), Scopus (2004–2018), Cochrane Central Register of Controlled Trials CENTRAL (1999–2018), Clinicaltrials.gov (2008–2018), and Google Scholar (2004–2018) databases. Statistical analysis was performed with Review Manager 5.3 and R 3.4.3.

Results

Meta-analysis included 14 studies, with a total of 2,625 patients. AKI incidence was significantly lower in the dexmedetomidine (OR 0.49, 95% CI [0.28–0.87]) and acetaminophen (OR 0.43, 94% CI [0.28–0.67]) groups, while no difference was present in patients receiving corticosteroid (OR 1.16, 95% CI [0.69–1.95]), fenoldopam (OR 0.47, 95% CI [0.22–1.02]), or aminophylline (OR 0.98, 95% CI [0.29–3.34]). Network meta-analysis proposed that dexmedetomidine had the greatest probability (44.5%) to rank first, although significant overlap with the other treatments was observed.

Conclusions

The present meta-analysis suggests that no firm evidence exists about the protective role of pharmacological interventions in the pediatric population. Future randomized controlled trials should clarify the effectiveness of dexmedetomidine and acetaminophen and indicate the optimal protocol to be applied, to protect renal function in the perioperative setting.

Keywords

Acute kidney injury Pediatric Cardiac surgery Prevention 

Notes

Funding

None.

Compliance with ethical standards

Conflict of interest

The authors have declared that no conflict of interest exists.

Informed consent

The present systematic review and meta-analysis is based on aggregated data that were retrieved from studies already retrieved. We did not collect individual patient data and did not have direct contact with patients included.

Supplementary material

10157_2019_1706_MOESM1_ESM.tif (25 kb)
Supplementary material 1 (TIF 24 KB)
10157_2019_1706_MOESM2_ESM.tif (95 kb)
Supplementary material 2 (TIF 95 KB)
10157_2019_1706_MOESM3_ESM.tif (398 kb)
Supplementary material 3 (TIF 397 KB)
10157_2019_1706_MOESM4_ESM.tif (50 kb)
Supplementary material 4 (TIF 50 KB)
10157_2019_1706_MOESM5_ESM.tif (353 kb)
Supplementary material 5 (TIF 353 KB)
10157_2019_1706_MOESM6_ESM.docx (19 kb)
Supplementary material 6 (DOCX 19 KB)
10157_2019_1706_MOESM7_ESM.docx (14 kb)
Supplementary material 7 (DOCX 14 KB)
10157_2019_1706_MOESM8_ESM.docx (14 kb)
Supplementary material 8 (DOCX 14 KB)

References

  1. 1.
    Hirano D, Ito A, Yamada A, Kakegawa D, Miwa S, Umeda C, et al. Independent risk factors and 2-year outcomes of acute kidney injury after surgery for congenital heart disease. Am J Nephrol. 2017;46:204–9.CrossRefGoogle Scholar
  2. 2.
    Madsen NL, Goldstein SL, Frøslev T, Christiansen CF, Olsen M. Cardiac surgery in patients with congenital heart disease is associated with acute kidney injury and the risk of chronic kidney disease. Kidney Int. 2017;92:751–6.CrossRefGoogle Scholar
  3. 3.
    Blinder JJ, Goldstein SL, Lee V-V, Baycroft A, Fraser CD, Nelson D, et al. Congenital heart surgery in infants: effects of acute kidney injury on outcomes. J Thorac Cardiovasc Surg. 2012;143:368–74.CrossRefGoogle Scholar
  4. 4.
    Li S, Krawczeski CD, Zappitelli M, Devarajan P, Thiessen-Philbrook H, Coca SG, et al. Incidence, risk factors, and outcomes of acute kidney injury after pediatric cardiac surgery: a prospective multicenter study*. Crit Care Med. 2011;39:1493–9.CrossRefGoogle Scholar
  5. 5.
    Leow EH, Chan YH, Ng YH, Lim JKB, Nakao M, Lee JH. Prevention of acute kidney injury in children undergoing cardiac surgery: a narrative review. World J Pediatr Congenit Heart Surg. 2018;9:79–90.CrossRefGoogle Scholar
  6. 6.
    Toda Y, Sugimoto K. AKI after pediatric cardiac surgery for congenital heart diseases-recent developments in diagnostic criteria and early diagnosis by biomarkers. J intensive care. 2017;5:49.CrossRefGoogle Scholar
  7. 7.
    Al-Ismaili Z, Palijan A, Zappitelli M. Biomarkers of acute kidney injury in children: discovery, evaluation, and clinical application. Pediatr Nephrol. 2011;26:29–40.CrossRefGoogle Scholar
  8. 8.
    Greenberg JH, Zappitelli M, Jia Y, Thiessen-Philbrook HR, de Fontnouvelle CA, Wilson FP, et al. Biomarkers of AKI progression after pediatric cardiac surgery. J Am Soc Nephrol. 2018;29:1549–56.CrossRefGoogle Scholar
  9. 9.
    Lee J-H, Jung J-Y, Park S-W, Song I-K, Kim E-H, Kim H-S, et al. Risk factors of acute kidney injury in children after cardiac surgery. Acta Anaesthesiol Scand. 2018;62(10):1374–82.CrossRefGoogle Scholar
  10. 10.
    Kramer RS, Herron CR, Groom RC, Brown JR. Acute kidney injury subsequent to cardiac surgery. J Extra Corpor Technol. 2015;47:16–28.Google Scholar
  11. 11.
    Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.CrossRefGoogle Scholar
  12. 12.
    Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.CrossRefGoogle Scholar
  13. 13.
    Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.CrossRefGoogle Scholar
  14. 14.
    Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.CrossRefGoogle Scholar
  15. 15.
    Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.CrossRefGoogle Scholar
  16. 16.
    Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. Karger Publ. 2012;120:c179–84.Google Scholar
  17. 17.
    Viechtbauer W. Conducting Meta-Analyses in R with the metafor Package. J Stat Softw. 2010;36:1–48.CrossRefGoogle Scholar
  18. 18.
    Souza JP, Pileggi C, Cecatti JG. Assessment of funnel plot asymmetry and publication bias in reproductive health meta-analyses: an analytic survey. Reprod Health. 2007;4:3.CrossRefGoogle Scholar
  19. 19.
    Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008;61:64–75.CrossRefGoogle Scholar
  20. 20.
    Lin L, Zhang J, Hodges JS, Chu H. Performing Arm-Based Network Meta-Analysis in R with the pcnetmeta Package. J Stat Softw. 2017;80:1–25.CrossRefGoogle Scholar
  21. 21.
    Plummer M. JAGS Software, version 4.0.0. 2015. http://mcmc-jags.sourceforge.net/. Accessed 5 Aug 2018.
  22. 22.
    Cowles MK, Carlin BP. Markov Chain Monte Carlo convergence diagnostics: a comparative review. J Am Stat Assoc. 1996;91:883–904.CrossRefGoogle Scholar
  23. 23.
    Higgins JPT, Jackson D, Barrett JK, Lu G, Ades AE, White IR. Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Res Synth Methods. 2012;3:98–110.CrossRefGoogle Scholar
  24. 24.
    Dalili M, Vesal A, Tabib A, Khani-Tafti L, Hosseini S, Totonchi Z. Single dose corticosteroid therapy after surgical repair of fallot’s tetralogy; a randomized controlled clinical trial. Res Cardiovasc Med. 2015;4:e25500.CrossRefGoogle Scholar
  25. 25.
    Bronicki RA, Backer CL, Baden HP, Mavroudis C, Crawford SE, Green TP. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg. 2000;69:1490–5.CrossRefGoogle Scholar
  26. 26.
    Elhoff JJ, Chowdhury SM, Zyblewski SC, Atz AM, Bradley SM, Graham EM. Intraoperative steroid use and outcomes following the norwood procedure. Pediatr Crit Care Med. 2016;17:30–5.CrossRefGoogle Scholar
  27. 27.
    Van Driest SL, Jooste EH, Shi Y, Choi L, Darghosian L, Hill KD, et al. Association between early postoperative acetaminophen exposure and acute kidney injury in pediatric patients undergoing cardiac surgery. JAMA Pediatr. 2018;172:655–63.CrossRefGoogle Scholar
  28. 28.
    Simpson SA, Zaccagni H, Bichell DP, Christian KG, Mettler BA, Donahue BS, et al. Acetaminophen attenuates lipid peroxidation in children undergoing cardiopulmonary bypass. Pediatr Crit Care Med. 2014;15:503–10.CrossRefGoogle Scholar
  29. 29.
    Jo YY, Kim JY, Lee JY, Choi CH, Chang YJ, Kwak HJ. The effect of intraoperative dexmedetomidine on acute kidney injury after pediatric congenital heart surgery: a prospective randomized trial. Medicine (Baltimore). 2017;96:e7480.CrossRefGoogle Scholar
  30. 30.
    Kwiatkowski DM, Axelrod DM, Sutherland SM, Tesoro TM, Krawczeski CD. Dexmedetomidine is associated with lower incidence of acute kidney injury after congenital heart surgery. Pediatr Crit Care Med. 2016;17:128–34.CrossRefGoogle Scholar
  31. 31.
    Onder AM, Rosen D, Mullett C, Cottrell L, Kanosky S, Grossman OK, et al. Comparison of intraoperative aminophylline versus furosemide in treatment of oliguria during pediatric cardiac surgery. Pediatr Crit Care Med. 2016;17:753–63.CrossRefGoogle Scholar
  32. 32.
    Axelrod DM, Sutherland SM, Anglemyer A, Grimm PC, Roth SJ, Double-Blinded A. Randomized, placebo-controlled clinical trial of aminophylline to prevent acute kidney injury in children following congenital heart surgery with cardiopulmonary bypass. Pediatr Crit Care Med. 2016;17:135–43.CrossRefGoogle Scholar
  33. 33.
    Ricci Z, Stazi GV, Di Chiara L, Morelli S, Vitale V, Giorni C, et al. Fenoldopam in newborn patients undergoing cardiopulmonary bypass: controlled clinical trial. Interact Cardiovasc Thorac Surg. 2008;7:1049–53.CrossRefGoogle Scholar
  34. 34.
    Ricci Z, Luciano R, Favia I, Garisto C, Muraca M, Morelli S, et al. High-dose fenoldopam reduces postoperative neutrophil gelatinase-associated lipocaline and cystatin C levels in pediatric cardiac surgery. Crit Care. 2011;15:R160.CrossRefGoogle Scholar
  35. 35.
    Pesonen EJ, Suominen PK, Keski-Nisula J, Mattila IP, Rautiainen P, Jahnukainen T. The effect of methylprednisolone on plasma concentrations of neutrophil gelatinase-associated lipocalin in pediatric heart surgery. Pediatr Crit Care Med. 2016;17:121–7.CrossRefGoogle Scholar
  36. 36.
    Morgan CJ, Gill PJ, Lam S, Joffe AR. Peri-operative interventions, but not inflammatory mediators, increase risk of acute kidney injury after cardiac surgery: a prospective cohort study. Intensive Care Med. 2013;39:934–41.CrossRefGoogle Scholar
  37. 37.
    Jahnukainen T, Keski-Nisula J, Tainio J, Valkonen H, Pätilä T, Jalanko H, et al. Efficacy of corticosteroids in prevention of acute kidney injury in neonates undergoing cardiac surgery-A randomized controlled trial. Acta Anaesthesiol Scand. 2018;62:1072–9.CrossRefGoogle Scholar
  38. 38.
    Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.CrossRefGoogle Scholar
  39. 39.
    Askenazi DJ, Bunchman TE. Pediatric acute kidney injury: the use of the RIFLE criteria. Kidney Int. 2007;71:963–4.CrossRefGoogle Scholar
  40. 40.
    Ando M, Park I-S, Wada N, Takahashi Y. Steroid supplementation: a legitimate pharmacotherapy after neonatal open heart surgery. Ann Thorac Surg. 2005;80:1672–8.CrossRefGoogle Scholar
  41. 41.
    Graham EM, Atz AM, Butts RJ, Baker NL, Zyblewski SC, Deardorff RL, et al. Standardized preoperative corticosteroid treatment in neonates undergoing cardiac surgery: results from a randomized trial. J Thorac Cardiovasc Surg. 2011;142:1523–9.CrossRefGoogle Scholar
  42. 42.
    Shahbazi S, Alishahi P, Asadpour E. Evaluation of the effect of aminophylline in reducing the incidence of acute kidney injury after cardiac surgery. Anesthesiol pain Med. 2017;7:e21740.CrossRefGoogle Scholar
  43. 43.
    Liu Y, Sheng B, Wang S, Lu F, Zhen J, Chen W. Dexmedetomidine prevents acute kidney injury after adult cardiac surgery: a meta-analysis of randomized controlled trials. BMC Anesthesiol. 2018;18:7.CrossRefGoogle Scholar
  44. 44.
    Tan F, Chen Y, Yuan D, Gong C, Li X, Zhou S. Dexmedetomidine protects against acute kidney injury through downregulating inflammatory reactions in endotoxemia rats. Biomed Rep. 2015;3:365–70.CrossRefGoogle Scholar
  45. 45.
    Gu J, Sun P, Zhao H, Watts HR, Sanders RD, Terrando N, et al. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care. 2011;15:R153.CrossRefGoogle Scholar
  46. 46.
    Fudulu DP, Gibbison B, Upton T, Stoica SC, Caputo M, Lightman S, et al. Corticosteroids in pediatric heart surgery: myth or reality. Front Pediatr. 2018;6:112.CrossRefGoogle Scholar
  47. 47.
    Marin T, DeRossett B, Bhatia J. Urinary biomarkers to predict neonatal acute kidney injury. J Perinat Neonatal Nurs. 2018;32:1.CrossRefGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2019

Authors and Affiliations

  1. 1.Laboratory of Experimental Surgery and Surgical Research N.S. Christeas, Athens University Medical SchoolNational and Kapodistrian University of AthensAthensGreece

Personalised recommendations